We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Detecting Mutations With Liquid Biopsies
Industry Insight

Here we summarize the webinar that was hosted by Monika Seidel Ph.D., in which she discussed detecting mutations with liquid biopsies in cancer diagnostics.

Read More

Meeting Renewed Regulatory Focus on Gene Therapy Safety Standards
Industry Insight

In this industry insights piece, we explore how gene therapies represent a rapidly growing new paradigm — both therapeutically and with respect to how they are managed within the larger scope of healthcare — and how this has wide-ranging impacts on several key areas, including regulation.

Read More

Eliciting the Hormetic Effect: The Importance of Plant Alkaloids for Treatment of Inflammation
Industry Insight

Today, plant alkaloids are attracting notice as novel therapies for conditions involving inflammation, such as metabolic syndrome, autoimmune disease and even for aging, which are often characterized by chronic, low-grade over-activation of the immune system. This piece takes a closer look at the need for novel treatments and the best uses for plant alkaloids.

Read More

PCR: The "Workhorse" Technology
Industry Insight

Technology Networks spoke with Dr Jan Hellemans, CTO and co-founder of CRO Biogazelle, as well as co-author of the MIQE guidelines, to learn why PCR-based technologies are the "workhorse" technologies for the company.

Read More

A "One-and-Done" Treatment To Protect Against Heart Disease?
Industry Insight

Verve Therapeutics is utilizing two of the biggest scientific breakthroughs of the twenty-first century – DNA sequencing and genome editing – to design a one-time treatment for lowering cholesterol.

Read More

The Impact of Emerging SARS-CoV-2 Variants on Diagnostic Testing
Industry Insight

The emergence of SARS-CoV-2 variants has led to concerns over the potential impacts there could be on the effectiveness of diagnostics and other countermeasures. Here, we look at the effects the B.1.1.7 variant may have on diagnostic tests.

Read More

Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Industry Insight

Technology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.

Read More

Staying Ahead of the Curve in the Californian Cannabis Testing Industry
Industry Insight

To find out more about cannabis testing in California and how CannaSafe is working hard to ensure consumers and patients receive contaminant-free and rigorously-tested cannabis, we spoke to their President, Aaron Riley.

Read More

3 Major Trends for Cardiac Drug Discovery in 2020
Industry Insight

Without a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.

Read More

How Will Genome UK Securely Handle 150 Petabases of Genomic Data?
Industry Insight

Genomic data company PetaGene recently sounded a warning that Genome UK, the UK government’s recently announced genomic healthcare strategy, needs to address important data handling challenges to maintain public trust. To find out more, Technology Networks spoke to PetaGene’s co-founder and chief commercial officer, Vaughan Wittorff, PhD, and co-founder and chief executive officer, Dan Greenfield, PhD.

Read More

 
Advertisement